Adherent cells from placenta and use of same in disease treatment
US10610545B2 · kind B2 · utility
2Cited by
10References
20Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 25, 2015 |
| Grant date | Apr 7, 2020 |
| Priority date | — |
| Expiry date | Aug 25, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2502/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods for treating conditions by administration of placenta derived adherent stromal cells to a subject in thereof are provided. Such conditions include skeletal muscle defects, neuropathic pain, and myocardial infarction. Also provided are methods wherein the adherent stromal cells administered are cultured under 2 dimensional or 3 dimensional growth conditions. Also provided are methods in which the cells administered are at least 70% adherent cells from a maternal or fetal portion of the placenta.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.